-
Synergistic roles for Pim-1 and c-Myc in STAT3-mediated cell cycle progression and antiapoptosis.
Immunity. 1999 Dec;11(6):709-19
PMID: 10626893
-
Identification of CDK4 as a target of c-MYC.
Proc Natl Acad Sci U S A. 2000 Feb 29;97(5):2229-34
PMID: 10688915
-
Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion.
Proc Natl Acad Sci U S A. 2000 Mar 28;97(7):3260-5
PMID: 10737792
-
Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo.
Proc Natl Acad Sci U S A. 2000 Apr 11;97(8):4227-32
PMID: 10760290
-
Activation of Stat3 preassembled with platelet-derived growth factor beta receptors requires Src kinase activity.
Oncogene. 2000 Apr 20;19(17):2075-85
PMID: 10815799
-
The role of STATs in transcriptional control and their impact on cellular function.
Oncogene. 2000 May 15;19(21):2468-73
PMID: 10851045
-
STATs in oncogenesis.
Oncogene. 2000 May 15;19(21):2474-88
PMID: 10851046
-
No requirement for src family kinases for PDGF signaling in fibroblasts expressing SV40 large T antigen.
Oncogene. 2000 Jun 1;19(24):2867-9
PMID: 10851090
-
Regulation of both apoptosis and cell survival by the v-Src oncoprotein.
Cell Death Differ. 2000 Aug;7(8):685-96
PMID: 10918442
-
Biochemical and cellular effects of c-Src kinase-selective pyrido[2, 3-d]pyrimidine tyrosine kinase inhibitors.
Biochem Pharmacol. 2000 Oct 1;60(7):885-98
PMID: 10974196
-
SU6656, a selective src family kinase inhibitor, used to probe growth factor signaling.
Mol Cell Biol. 2000 Dec;20(23):9018-27
PMID: 11074000
-
v-Src generates a p53-independent apoptotic signal.
Mol Cell Biol. 2000 Dec;20(24):9271-80
PMID: 11094078
-
Induction of p21WAF1/CIP1 and cyclin D1 expression by the Src oncoprotein in mouse fibroblasts: role of activated STAT3 signaling.
Oncogene. 2000 Nov 16;19(48):5419-27
PMID: 11114718
-
A modest reduction in c-myc expression has minimal effects on cell growth and apoptosis but dramatically reduces susceptibility to Ras and Raf transformation.
Cancer Res. 2001 Feb 1;61(3):1178-86
PMID: 11221849
-
Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor.
Cell. 1983 Dec;35(3 Pt 2):603-10
PMID: 6606489
-
Protein-tyrosine kinases.
Annu Rev Biochem. 1985;54:897-930
PMID: 2992362
-
Platelet-derived growth factor induces multisite phosphorylation of pp60c-src and increases its protein-tyrosine kinase activity.
Mol Cell Biol. 1988 Aug;8(8):3345-56
PMID: 2463476
-
The SIF binding element confers sis/PDGF inducibility onto the c-fos promoter.
EMBO J. 1990 Dec;9(13):4477-84
PMID: 2176154
-
Molecular themes in oncogenesis.
Cell. 1991 Jan 25;64(2):235-48
PMID: 1988146
-
Gene therapy with dominant-negative Stat3 suppresses growth of the murine melanoma B16 tumor in vivo.
Cancer Res. 1999 Oct 15;59(20):5059-63
PMID: 10537273
-
STAT proteins as novel targets for cancer therapy. Signal transducer an activator of transcription.
Curr Opin Oncol. 1999 Nov;11(6):490-6
PMID: 10550013
-
Function of the c-Myc oncogenic transcription factor.
Exp Cell Res. 1999 Nov 25;253(1):63-77
PMID: 10579912
-
Dominant negative MYC blocks transformation by ABL oncogenes.
Cell. 1992 Sep 18;70(6):901-10
PMID: 1525828
-
The Src family tyrosine kinases are required for platelet-derived growth factor-mediated signal transduction in NIH 3T3 cells.
Proc Natl Acad Sci U S A. 1993 Aug 15;90(16):7696-700
PMID: 8356071
-
Ras-independent growth factor signaling by transcription factor tyrosine phosphorylation.
Science. 1993 Sep 24;261(5129):1736-9
PMID: 8378775
-
Differential complementation of Bcr-Abl point mutants with c-Myc.
Science. 1994 Apr 15;264(5157):424-6
PMID: 8153630
-
DNA synthesis induced by some but not all growth factors requires Src family protein tyrosine kinases.
Mol Cell Biol. 1995 Feb;15(2):1102-9
PMID: 7823926
-
Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein.
Science. 1995 Jul 7;269(5220):81-3
PMID: 7541555
-
Jak-STAT signaling induced by the v-abl oncogene.
Science. 1995 Sep 29;269(5232):1875-7
PMID: 7569929
-
Myc but not Fos rescue of PDGF signalling block caused by kinase-inactive Src.
Nature. 1995 Nov 30;378(6556):509-12
PMID: 7477410
-
Expression of dominant-negative mutant DP-1 blocks cell cycle progression in G1.
Mol Cell Biol. 1996 Jul;16(7):3698-706
PMID: 8668186
-
STAT3beta, a splice variant of transcription factor STAT3, is a dominant negative regulator of transcription.
J Biol Chem. 1996 May 31;271(22):13221-7
PMID: 8675499
-
Requirement for c-Src catalytic activity and the SH3 domain in platelet-derived growth factor BB and epidermal growth factor mitogenic signaling.
J Biol Chem. 1996 Jul 12;271(28):16798-806
PMID: 8663329
-
Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: involvement of STAT3 in anti-apoptosis.
Immunity. 1996 Nov;5(5):449-60
PMID: 8934572
-
STATs and gene regulation.
Science. 1997 Sep 12;277(5332):1630-5
PMID: 9287210
-
Phenotypes of c-Myc-deficient rat fibroblasts isolated by targeted homologous recombination.
Cell Growth Differ. 1997 Oct;8(10):1039-48
PMID: 9342182
-
Constitutive activation of Stat3 in fibroblasts transformed by diverse oncoproteins and in breast carcinoma cells.
Cell Growth Differ. 1997 Dec;8(12):1267-76
PMID: 9419415
-
Stat3 activation by Src induces specific gene regulation and is required for cell transformation.
Mol Cell Biol. 1998 May;18(5):2545-52
PMID: 9566874
-
Stat3 activation is required for cellular transformation by v-src.
Mol Cell Biol. 1998 May;18(5):2553-8
PMID: 9566875
-
How cells respond to interferons.
Annu Rev Biochem. 1998;67:227-64
PMID: 9759489
-
STAT3 orchestrates contradictory signals in cytokine-induced G1 to S cell-cycle transition.
EMBO J. 1998 Nov 16;17(22):6670-7
PMID: 9822610
-
STAT3 is required for the gp130-mediated full activation of the c-myc gene.
J Exp Med. 1999 Jan 4;189(1):63-73
PMID: 9874564
-
Complementation of defective colony-stimulating factor 1 receptor signaling and mitogenesis by Raf and v-Src.
Mol Cell Biol. 1999 Feb;19(2):1101-15
PMID: 9891045
-
A single amino acid substitution in the v-Eyk intracellular domain results in activation of Stat3 and enhances cellular transformation.
Mol Cell Biol. 1999 Feb;19(2):1401-9
PMID: 9891073
-
Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells.
Immunity. 1999 Jan;10(1):105-15
PMID: 10023775
-
c-Src, receptor tyrosine kinases, and human cancer.
Adv Cancer Res. 1999;76:61-119
PMID: 10218099
-
c-Myc regulates cyclin D-Cdk4 and -Cdk6 activity but affects cell cycle progression at multiple independent points.
Mol Cell Biol. 1999 Jul;19(7):4672-83
PMID: 10373516
-
Mysterious liaisons: the relationship between c-Myc and the cell cycle.
Oncogene. 1999 May 13;18(19):2934-41
PMID: 10378690
-
Fetal anemia and apoptosis of red cell progenitors in Stat5a-/-5b-/- mice: a direct role for Stat5 in Bcl-X(L) induction.
Cell. 1999 Jul 23;98(2):181-91
PMID: 10428030
-
Stat3 as an oncogene.
Cell. 1999 Aug 6;98(3):295-303
PMID: 10458605
-
Requirement for Ras/Rac1-mediated p38 and c-Jun N-terminal kinase signaling in Stat3 transcriptional activity induced by the Src oncoprotein.
Mol Cell Biol. 1999 Nov;19(11):7519-28
PMID: 10523640